Add this topic to your myFT Digest for news straight to your inbox
You select the topic, we deliver the news.
Sample the FT’s top stories for a week
Producers and campaigners lock horns over rules on nutrition claims
Temporary halt to some new patients on trials for immunotherapy treatment durvalumab
Decision on drug for muscular dystrophy exposes deep divisions at watchdog
An FT analysis shows big pharma still makes billions from drugs after patents lapse